Safety and efficacy of pralatrexate combined with bortezomib in elderly patients with relapsed or refractory peripheral T cell lymphoma
Latest Information Update: 08 Jul 2016
At a glance
- Drugs Bortezomib (Primary) ; Pralatrexate (Primary)
- Indications Peripheral T-cell lymphoma
- Focus Adverse reactions; Therapeutic Use
- 08 Jul 2016 New trial record
- 01 Jul 2016 Results published in the Journal of Korean Medical Science